Stock Market Today: Dow Jones, S&P 500 Futures Rise Ahead of Apple, Palantir Earnings

U.S. stocks rose on Monday as the Dow Jones, S&P 500, and Nasdaq 100 index futures advanced following Friday's lower close. President Donald Trump said Sunday that the U.S. has already won in Iran and will wrap up the war soon, either through a deal with Tehran or by ending it on its own. Ahead of Tuesday's midterms, he told Right Side Broadcasting Network before a campaign rally in Iowa on Sunday that we've had such a victory and that the U.S. will put it away very soon, one way or the other. Separately, Iran's security chief Mohsen Rezaei criticized European governments over the economic fallout of the Iran war. After German Chancellor Friedrich Merz said Europe had incurred more than 100 billion euros, around 112 billion dollars, in additional energy costs over the past eight months because of the conflict. Meanwhile, the 10-year treasury bond yielded 4.91 percent and the two-year treasury bond yielded 4.59 percent at the last check. The CME Group's FedWatch tool projections show markets pricing in a 72.9% likelihood. of the Federal Reserve hiking interest rates after its December meeting. The SPDR S&P 500 ETF Trust, the Invesco QQQ Trust ETF, and the SPDR Dow Jones Industrial Average ETF Trust were higher in pre-market trading on Monday. The SPY was up 0.48% at $759.31. The QQQ advanced 0.88% to $696.59 And the DIA rose 0.43% to $519.34. Stocks in focus for today are Ryanair Holdings was 0.73% higher in pre-market trading on Monday after it reported second quarter 2027 earnings before the opening bell, beating estimates with EPS of $3.54 versus $3.49 and revenue of $6.56 billion. versus $6.47 billion. United States Lime and Minerals was 1.08% lower in pre-market trading on Monday after it reported third quarter 2026 earnings. Missing estimates with EPS of $1.32 versus $1.48 and revenue of $106.19 million versus $122 million. Inovio Pharmaceuticals was 217.90% higher in pre-market trading on Monday after the FDA granted accelerated approval for Voseric for the treatment of adults with recurrent respiratory papillomatosis. Apple was 0.41% lower in pre-market trading on Monday as analysts expect fourth quarter 2026 EPS of $1.99. On revenue of $113.38 billion after the closing bell. Palantir Technologies was 1.47% higher in pre-market trading on Monday, as analysts expect third quarter 2026 EPS of $0.41 on revenue of $2.18 billion after the closing bell. Thank you for watching and make sure to subscribe.